This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
home-builder: Archive
Is ClearBridge Small Cap Growth A (SASMX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for SASMX
SASMXNegative Net Change
equity home-builder mutual-funds
Is the Options Market Predicting a Spike in Redwood Trust Stock?
by Zacks Equity Research
Investors need to pay close attention to RWT stock based on the movements in the options market lately.
RWTNegative Net Change
home-builder home-buying-apps
Is Lennar (LEN) a 'Buy' Ahead of Its Upcoming Earnings Announcement?
by Bryan Hayes
Ongoing pressures on margins and housing affordability remain key concerns.
LENPositive Net Change
construction earnings home-builder housing investing stock-performance
Housing Starts Decreased in August
by Zacks Equity Research
Housing Starts Decreased in August
TOLPositive Net Change
finance home-builder
Is Builder Confidence Set to Rebound on Looming Fed Rate Cuts?
by Shrabana Mukherjee
Builder confidence stayed flat in September, but falling mortgage rates may spark a housing market rebound, with stocks like DHI, TOL, HD, LOW and MAS already gaining ground.
LOWPositive Net Change HDPositive Net Change MASNegative Net Change TOLPositive Net Change DHIPositive Net Change
construction home-builder
Housing Numbers Down Ahead of Fed Rate Cut Today
by Mark Vickery
With expectations high that interest rates will come down further in the near future, it keeps some homebuying prospects on the sidelines.
TOLPositive Net Change QQQPositive Net Change SPYPositive Net Change DIAPositive Net Change
home-builder inflation interest-rate
After Golden Cross, Strawberry Fields REIT, Inc. (STRW)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
STRWPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is Franklin Biotechnology Discovery A (FBDIX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for FBDIX
FBDIXNegative Net Change
equity home-builder mutual-funds
Is Loomis Sayles Growth Fund A (LGRRX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for LGRRX
LGRRXPositive Net Change
equity home-builder mutual-funds
Is Victory Science & Technology (USSCX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for USSCX
USSCXNegative Net Change
equity home-builder mutual-funds
Is Fidelity Select Financial Services (FIDSX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for FIDSX
FIDSXNegative Net Change
equity home-builder mutual-funds
Is Putnam Global Technology A (PGTAX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for PGTAX
PGTAXNegative Net Change
equity home-builder mutual-funds
Markets Sell Ahead of FOMC Rate Cut
by Mark Vickery
The Nasdaq looked as if it may eke out a green close, but dipped just ahead of the bell.
CBRLPositive Net Change GISPositive Net Change
home-builder interest-rate
Lennar Before Q3 Earnings: Should You Buy, Sell or Hold the Stock?
by Sraddha Singha
With LEN's Q3 earnings looming, will sales incentives and delivery gains outweigh margin pressures and valuation risks?
PHMPositive Net Change KBHPositive Net Change LENPositive Net Change DHIPositive Net Change
construction earnings home-builder
Is Vanguard Total International Stock Index AD (VTIAX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for VTIAX
VTIAXNegative Net Change
equity home-builder mutual-funds
Is JPMorgan Small Cap Blend A (VSCOX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for VSCOX
VSCOXNegative Net Change
equity home-builder mutual-funds
Is Fidelity Select Chemicals (FSCHX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for FSCHX
FSCHXNegative Net Change
equity home-builder mutual-funds
Is Morgan Stanley Inst Global Opp I (MGGIX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for MGGIX
MGGIXNegative Net Change
equity home-builder mutual-funds
Should You Buy Pyxis Oncology, Inc. (PYXS) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
PYXSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Howard Hughes Holdings (HHH) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
HHHPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Will Toll Brothers' $13.75 EPS Target Hold Amid Softer Sales Volumes?
by Amit Kr Ram
TOL faces softer demand, but pricing power and efficiency gains can help sustain its 2025 EPS target.
TOLPositive Net Change LENPositive Net Change DHIPositive Net Change
construction home-builder
Is T. Rowe Price US Equity Research (PRCOX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for PRCOX
PRCOXNegative Net Change
equity home-builder mutual-funds
Is Vanguard Small-Cap Index Admiral (VSMAX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for VSMAX
VSMAXNegative Net Change
equity home-builder mutual-funds
Is Vanguard Health Care Index Admiral (VHCIX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for VHCIX
VHCIXNegative Net Change
equity home-builder mutual-funds
Is Vanguard Total Stock Market Index Admiral (VTSAX) a Strong Mutual Fund Pick Right Now?
by Zacks Equity Research
Mutual Fund Report for VTSAX
VTSAXPositive Net Change
equity home-builder mutual-funds